Worldwide Healthcare News

Ophthalmic Devices Market Report , published by Allied Market Research, forecasts that the global market was valued at $46,029 million in 2015, and is expected to reach $62,113 million by 2022, supported by a CAGR of 4.3% during the forecast period 2014 to 2022. The vision care devices segment dominated the global market, accounting for a share of nearly half of the total market in 2015. Download the Sample Report @  http://bit.ly/2HLsXvx Ophthalmology is a branch of medical sciences, which deals with structure, function, and various diseases related to the eye. The ophthalmic device based on the product function are majorly categorized into surgical, diagnostic, and vision care devices. The increase in prevalence of eye related diseases such as glaucoma, cataract, refractive errors, AMD, and others drive the global ophthalmic devices market. Increase in prevalence and technological advancements in the devices also fuel the growth of the market. Increase in prevalence rate of

The Middle East disposable gloves market was valued at $355.9 million in 2017, and is expected to reach $615.1 million by 2025 at a CAGR of 7.04% during the forecast period. In terms of volume, polyethylene gloves exhibited the highest growth throughout the forecast period.  Download the Sample Report @  http://bit.ly/2xkjVRw Disposable gloves are primarily used in the healthcare and food industry, as a protection measure to avoid cross-infection between caregivers and patients. Over the period, a number of variants of disposable gloves have been developed such as natural rubber, nitrile, vinyl, and neoprene. Each of the variants renders a unique benefit over conventional gloves, which in turn increases its applications in various industries such as food service, clean room, and industrial application. For instance, nitrile gloves are more puncture-resistant, frictionless, and offer longer shelf life as compared to latex gloves. The major factors driving the growth of the dispo

Smart pill is a technological innovation that has bridged the unsought gap between healthcare and digital technology. The advent of novel smart pill technologies has revolutionized gastrointestinal (GI) monitoring and diagnosis techniques. Non-invasiveness, patient convenience and real time monitoring offered by smart pills boost their adoption in the treatment of numerous diseases. The growth of global smart pills technology market is supplemented by the growing adoption of capsule endoscopy, spurring demand for smart pills in GI monitoring and the rising prevalence of gastrointestinal diseases. However, factors such as high costs, limited technical know-how and low acceptance among patients (fear of ingesting electronic devices) are likely to restrain the growth of the market. Download the Sample Report @  http://bit.ly/2F4CXPW Global Smart Pills Technology Market   Report ,  published by Allied Market Research, forecasts that the global market is expected to garner $627.1 mill

Ostomy Drainage Bags Market report,  published by Allied Market Research, forecasts that the global market is expected to garner$3,524 million by 2022, growing at a CAGR of 3.6% during the period 2016-2022. Download the Sample Report @  http://bit.ly/2ZVyl6Q The ostomy drainage bags market was valued at $2,742 million in 2015, and is expected to reach $3,524 million by 2022, growing at a CAGR of 3.6% from 2016 to 2022. High prevalence of colorectal cancer owing to the increase in geriatric population drives the market growth. Increase in population prone to colon cancer, urinary tract cancer, bladder cancer, colorectal cancer, inflammatory bowel disease, and chronic diseases such as ulcerative colitis and Crohns disease that require ostomy surgery, further boosts the market growth. Launch of new ostomy products with desirable features and technological advancements would propel adoption of these products. says Hemali Narkhede, Manager, Healthcare Research at Allied Mark

Radiofrequency Ablation Devices Market   Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,785 million by 2022, registering a CAGR of 11.8% during the period 2016-2022.  The disposable devices segment dominated the market in 2015 and is expected to lead throughout analysis period. Download the Sample Report @  http://bit.ly/2X8rBk3 The global radiofrequency ablation devices (RFAD) market has witnessed an unprecedented growth in the past few years. The rise in the incidence of patients with chronic pain due to the increase in the prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis have contributed towards the market growth. Factors such as large undiagnosed patient population, increasing urbanization, and growing awareness about radiofrequency ablation devices in the Asia-Pacific and Latin American is expected to contribute significantly towards the market growth. The market growth is expected to ma

Global Specialty Enzymes market is expected to register a CAGR of 9.4% during 2015-2020. The pharmaceuticals application segment accounted for about half of the overall market share in 2014. The Asia Pacific market would exhibit the highest CAGR of 11.7% during the forecast period (2015-2020). Download the Sample Report @  http://bit.ly/2ZSDxbx Specialty enzymes are proteins that act as biocatalysts to accelerate chemical reactions and produce the desired results. Owing to low consumption and high degree of specificity, specialty enzymes are witnessing spurring demand in medical applications such as pharmaceutical, biotechnology research and diagnostics. The growing popularity of specialty enzymes in therapies for chronic diseases such as cancer, cardiovascular diseases, pain and inflammatory disorders among others is the vital force fueling the market growth. In addition, growing awareness about enzyme-based therapeutics in the Asia Pacific and LAMEA region would further boost t

Global Micromanipulators Market  report by Allied Market Research, states that the sales of micromanipulators are projected to grow at a CAGR of 25.8% between 2015 and 2020. In 2014, cell micromanipulation application segment dominated the micromanipulators market in terms of both, revenue and volume, and is expected to retain its lead position during the forecast period. Download the Sample Report @  http://bit.ly/2wQXjI4 Shift from conventional manual micromanipulators to advanced electric or hydraulic versions, rising global infertility rates, and expanding base of semiconductors and microelectronics in the emerging economies are primarily leveraging the growth of the market. In addition, increasing usage of micromanipulator novel applications such as genomics, proteomics, transgenesis and cell cloning would provide continued growth thrust for the market. However, factors such as high cost associated with advanced micromanipulators, lack of awareness among potential end users

Medical/Diagnostic Imaging Market   Report , published by Allied Market Research, forecasts that the global market is expected to garner $45.0 billion by 2022, registering a CAGR of 5.1% during the period 2015-2022.  X-ray imaging systems are expected to continue to be the highest revenue-generating segment throughout the forecast period. North America accounted for around one-third of the market share in 2015, and is expected to dominate the overall market during the study period. Download the Sample Report @  http://bit.ly/2XpAt9m The cardiovascular and thoracic disease application segment is projected to maintain its lead throughout the analysis period owing to increase in the number of medical imaging services and technological advancements. In addition, technological innovations in the imaging industry have facilitated the development of cost-effective and smaller point-of-care ultrasound systems for cardiac evaluation. Mammography systems has emerged as the fastest growing

Body Composition Analyzers Market by Product and by End Users: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 , the market was valued at $356 million in 2017, and is projected to reach $596 million by 2025, growing at a CAGR of 6.6% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Download the Sample Report @  http://bit.ly/2Nfrh3r Body composition is the ratio of fat and fat-free mass in the body. Body composition analysis is required to measure and to assess health and fitness level of obese patients or other fitness-conscious people. Body composition analyzer is a device, which provides fast in-depth information for personalized health or fitness consultations. In addition, it is used to strategize an exercise plan as per the requirement of the end user. Multiple ways are available to measure body composition, and each method has its pros and cons. Body composition analyzers also help calcul

The Global AI in the healthcare market was valued at $1,441 million in 2016, and is estimated to reach at $22,790 million by 2023, registering a CAGR of 48.7% from 2017 to 2023. North America is the highest contributor in the AI in healthcare market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Download the Sample Report @  http://bit.ly/2M5Rlxe AI involves the science and engineering of intelligent computer programs. It uses various computer functions such reasoning, learning and problem solving based on human intelligence. AI systems can be used in various disciplines such as biology, computer science, mathematics, linguistics, psychology, and engineering to build an intelligent system. Some of the different applications that incorporate the AI systems in healthcare fields are medication management, treatment plans, and drug discovery. The global the AI market is driven by the ability of AI to improve patient outcome

Anesthesia and respiratory devices market accounted for $23,446 million in 2016, and is estimated to reach $38,298 million by 2023, registering a CAGR of 7.2% from 2017 to 2023. North America was the highest contributor in the anesthesia and respiratory devices market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Download the Sample Report @  http://bit.ly/2KchsjB Respiratory care is a healthcare specialty focused on improving cardiopulmonary functions and promoting health and wellness. Respiratory care devices are majorly classified into therapeutic, diagnostic & monitoring devices, and consumables & accessories. These devices are used to deal with medical conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and other acute & chronic respiratory diseases, in hospitals and homecare settings. Anesthesia is a medical procedure used to provide sedation to the patients using anesthetics to co

Antifungal drugs market was valued at $13,719 million in 2016, and is projected to reach $17,718 million by 2023, growing at a CAGR of 3.7% from 2017 to 2023. The azoles drug segment accounted for nearly three-eighths share of the total market in 2016. Download the Sample Report @  http://bit.ly/2Qywd1e Antifungal drugs are medications that selectively eliminate fungal infections from the host. These fungal agents multiply by spreading spores that subsequently lead to infection on skin, hairs, vagina, and other body parts. The fungal infection causes candidiasis, fungal pneumonia, mucormycosis, and other diseases. The antifungal drugs market is continuously growing and evolving owing to robust developmental efforts made by researchers and market players in the field. The growth in prevalence of fungal infection, rise in awareness levels pertaining to myriad fungal infections, and increase in demands of generic drugs are the major factors that drive the market growth. However, p

Breast biopsy market was valued at $977 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Core needle biopsy (CNB) segment accounted for about half of the global market share in 2016. Download the Sample Report @  http://bit.ly/2ZbTB82 A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures. The majo

Radiology Information System Market  report, published by Allied Market Research, forecasts that the global market is expected to garner $941 million by 2022, registering a CAGR of 5.9% during the period 2016-2022. The integrated radiology information systems segment held over three-fifths share of the total market in 2015. Download the Sample Report @  http://bit.ly/2MuJPfR Radiology information system (RIS) is a computer networked system used to organize and manage the workflow of medical imagery and radiology department, supporting business analysis in a department. RIS is widely used along with picture archiving and communication system (PACS) and vendor neutral archive to manage billing, record keeping, and image archives. The integrated radiology information systems held the largest share in 2015 and is expected to grow at the highest CAGR of 6.0% during the analysis period. This is owing to the surging adoption and demand of integrated healthcare information technology p

Global biomaterials market   is expected to reach $139 billion by 2022, from $62 billion in 2015, growing at a CAGR of 11.8% from 2016 to 2022, according to Allied Market Research. Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period. Download the Sample Report @  http://bit.ly/2ZV0qLv Metallic biomaterials segment contributed the highest revenue share to the global market, owing to highly used in orthopedic treatments for bone support and replacement, due to their strength and resistance to fatigue degradation. Polymeric biomaterials segment is projected to grow at a CAGR of 13.0% from 2016 to 2022, due to increasing demand for biodegradable products, and their use in various applications due their unique features such as flexibility, lightweight, remarkable biocompatibility, and physical

"Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications", adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc.'s new cost-effective genome machine HiSeq X Ten -the world's first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome. Download the Sample Report @  http://bit.ly/2xgU10S DNA diagnostics Market  Report, published by Allied Market Research, forecasts that the global market is expected to garner $19 billion by 2020, registering a CAGR of 9.8% during the period 2014-2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market. AMR analysis suggests that the tremendous potential of novel DNA diagnostic

CRPC Therapeutics Market   Report , published by Allied Market Research, forecasts that the global market is expected to garner $9.5 billion by 2020, registering a CAGR of 9.1% during the period 2015-2020.  Hormonal therapy segment spearheads among all the therapy types, governing around 4/5th of the global market value in 2014 and would sustain its market position throughout 2020. Download the Sample Report @   http://bit.ly/2QylgNq The global CPRC therapeutics market has witnessed high growth in the past few years and would continue to grow at a consistent pace due to the high unmet clinical need associated with the disease. Large amount of drugs in pipeline, augmented patient awareness and untapped nmCRPC space would largely drive the market growth during the forecast period. On the other hand, introduction of novel treatments would be difficult as long as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require an improvement in overall survival